After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
KNSA belongs to the Healthcare sector of the NASDAQ while operating in the Drug Manufacturers – Specialty & Generic industry. The current market capitalization of Kiniksa Pharmaceuticals International Plc is $2.10B. A total of 0.7 million shares were traded on the day, compared to an average of 777.58K shares.
In the most recent transaction, Tessari Eben sold 18,900 shares of KNSA for 28.72 per share on Jul 14 ’25. After the transaction, the CHIEF OPERATING OFFICER now owns 49,163 company shares. In a previous transaction on Jul 14 ’25, Tessari Eben bought 18,900 shares at 28.72 per share.
Among the insiders who sold shares, Tessari Eben disposed of 17,300 shares on Jun 16 ’25 at a per-share price of $28.28. This resulted in the CHIEF OPERATING OFFICER holding 61,563 shares of KNSA after the transaction. In another insider transaction, Tessari Eben bought 17,300 shares at $28.28 per share on Jun 16 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, KNSA has a high of $30.69 and a low of $17.82.
As of this writing, KNSA has an earnings estimate of $0.23 per share for the current quarter. EPS was calculated based on a consensus of 5.0 estimates, with a high estimate of $0.37 per share and a lower estimate of $0.14.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. KNSA’s latest balance sheet shows that the firm has $182.20M in Cash & Short Term Investments as of fiscal 2021. There were $6.05M in debt and $44.82M in liabilities at the time. Its Book Value Per Share was $6.28, while its Total Shareholder’s Equity was $185.04M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
